Hydrodissection of the Hepatoduodenal Ligament

Hepatic Lesions Clinical Trial

— Duodenal  

Official title:

Hydrodissection of the Hepatoduodenal Ligament

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06190821
• Other study ID #: 8695
• Status: Recruiting
• Start date: July 20, 2022
• Est. completion date: February 20, 2025

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: Julien GARNON, MD
• Phone: 33 3.69.55.03.04
• Email: julien.garnon[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate the feasibility of hepato duodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 13
• Est. completion date: February 20, 2025
• Est. primary completion date: February 2025
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Major subject (=18 years of age)

• Subject who underwent percutaneous ablation of primary or secondary liver lesions at HUS that required per-procedure hepatoduodenal ligament hydrodissection in the interventional imaging department of the New Civil Hospital from January 2019 to July 2022.

• Subject who has not expressed opposition to the reuse of their data for the purpose of this research.

Exclusion Criteria:

• Opposition to the reuse of his/her data for the purpose of scientific research.

Related Conditions & MeSH terms

• Hepatic Lesions

Locations

Country	Name	City	State
France	Service Imagerie interventionnelle oncologique et viscérale - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective description of the hepatoduodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum	This study is retrospective	Files analysed retrospectively from January 01, 2019 to July 31, 2022 will be examined